跳转至内容
Merck
CN

A1737

A922500

synthetic (organic), >95% (HPLC), Diacylglycerol acyltransferase inhibitor, powder

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C26H24N2O4
化学文摘社编号:
分子量:
428.48
MDL number:
UNSPSC Code:
12352204
NACRES:
NA.77
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

A922500,

SMILES string

N(c2ccc(cc2)c3ccc(cc3)C(=O)[C@H]4[C@@H](CCC4)C(=O)O)C(=O)Nc1ccccc1

InChI

1S/C26H24N2O4/c29-24(22-7-4-8-23(22)25(30)31)19-11-9-17(10-12-19)18-13-15-21(16-14-18)28-26(32)27-20-5-2-1-3-6-20/h1-3,5-6,9-16,22-23H,4,7-8H2,(H,30,31)(H2,27,28,32)/t22-,23-/m1/s1

InChI key

BOZRFEQDOFSZBV-DHIUTWEWSA-N

biological source

synthetic (organic)

assay

>95% (HPLC)

form

powder

mol wt

Mw 428.5

solubility

DMSO: 10 mg/mL, clear, colorless to greenish-yellow

storage temp.

−20°C

Quality Level

Application

A922500 已用于抑制上皮人乳腺癌细胞系(MDA-MB-231)、毛地黄皂苷透化的人癌细胞、人肌管和巨噬细胞中的二酰基甘油酰基转移酶(DGAT)。

Biochem/physiol Actions

二酰基甘油酰基转移酶(DGAT-1)抑制剂; IC50 7 至 24 nM
二酰基甘油酰基转移酶(DGAT)1 抑制剂 A922500 在 0.03、0.3 和 3 mg/kg 浓度下可有效降低啮齿动物的餐后血清甘油三酯水平。这些结果表明 A922500 可能有助于降低心血管疾病风险。

Physical form

A922500 以结晶固体形式提供。

Preparation Note

储备溶液可以通过将 A922500 溶解在所选溶剂中来制备。A922500 可溶于乙醇、DMSO 和二甲基甲酰胺(DMF)等有机溶剂。

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Lipid droplets induced by secreted phospholipase A2 and unsaturated fatty acids protect breast cancer cells from nutrient and lipotoxic stress
Jarc E, et al.
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1863(3), 247-265 (2018)
A specific lipid metabolic profile is associated with the epithelial mesenchymal transition program
Giudetti AM, et al.
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, 1864(3), 344-357 (2019)
Andrew J King et al.
European journal of pharmacology, 637(1-3), 155-161 (2010-04-14)
Postprandial serum triglyceride concentrations have recently been identified as a major, independent risk factor for future cardiovascular events. As a result, postprandial hyperlipidemia has emerged as a potential therapeutic target. The purpose of this study was two-fold. Firstly, to describe
Increased triacylglycerol-Fatty acid substrate cycling in human skeletal muscle cells exposed to eicosapentaenoic acid
Lovsletten NG, et al.
PLoS ONE, 13(11), e0208048-e0208048 (2018)
A Snake Venom-Secreted Phospholipase A2 Induces Foam Cell Formation Depending on the Activation of Factors Involved in Lipid Homeostasis
Leiguez E, et al.
Mediators of Inflammation, 2018 (2018)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持